Skip to content
naulon

No retraction, correction or concern found when last checked on Nov 4, 2026.

Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium

Satria P. Sajuthi, Peter DeFord, Yingchun Li and 25 more

Nature Communications · 2020 · CC BY

doi:10.1038/s41467-020-18781-2

Abstract

Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, an emerging virus that utilizes host proteins ACE2 and TMPRSS2 as entry factors. Understanding the factors affecting the pattern and levels of expression of these genes is important for deeper understanding of SARS-CoV-2 tropism and pathogenesis. Here we explore the role of genetics and co-expression networks in regulating these genes in the airway, through the analysis of nasal airway transcriptome data from 695 children. We identify expression quantitative trait loci for both ACE2 and TMPRSS2 , that vary in frequency across world populations. We find TMPRSS2 is part of a mucus secretory network, highly upregulated by type 2 (T2) inflammation through the action of interleukin-13, and that the interferon response to respiratory viruses highly upregulates ACE2 expression. IL-13 and virus infection mediated effects on ACE2 expression were also observed at the protein level in the airway epithelium. Finally, we define airway responses to common coronavirus infections in children, finding that these infections generate host responses similar to other viral species, including upregulation of IL6 and ACE2 . Our results reveal possible mechanisms influencing SARS-CoV-2 infectivity and COVID-19 clinical outcomes.

References 82

  1. 1.

    Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470-473.

    Not in our library10.1016/s0140-6736(20)30185-9

  2. 2.

    Zhu N, et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727-733.

    Not in our library10.1056/nejmoa2001017

  3. 3.

    Baud, D. et al. Real estimates of mortality following COVID-19 infection. Lancet Infect. Dis.20, 773 (2020).

    Not in our library10.1016/s1473-3099(20)30195-x

  4. 4.

    Du, Y. et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study. Am. J. Respir. Crit. Care Med.201, 1372–1379 (2020).

    Not in our library10.1164/rccm.202003-0543oc

  5. 5.

    Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062.

    Not in our library10.1016/s0140-6736(20)30566-3

  6. 6.
  7. 7.

    Dong, Y. et al. Epidemiology of COVID-19 among children in China. Pediatrics 145, 10.1542/peds.2020-0702 (2020).

    Not in our library10.1542/peds.2020-0702

  8. 8.

    Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell181, 271–280.e8 (2020).

    Not in our library10.1016/j.cell.2020.02.052

  9. 9.
  10. 10.

    Montoro DT, et al. A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature. 2018;560:319-324.

    Not in our library10.1038/s41586-018-0393-7

  11. 11.

    Plasschaert LW, et al. A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte. Nature. 2018;560:377-381.

    Not in our library10.1038/s41586-018-0394-6

  12. 12.

    Woodruff PG, et al. T-helper Type 2-driven inflammation defines major subphenotypes of asthma. Am. J. Respir. Crit. Care Med. 2009;180:388-395.

    Not in our library10.1164/rccm.200903-0392oc

  13. 13.

    Barcelo B, et al. Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease. Clin. Exp. Immunol. 2006;145:474-479.

    Not in our library10.1111/j.1365-2249.2006.03167.x

  14. 14.

    George L, Brightling CE. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease. Therap. Adv. Chronic Dis. 2016;7:34-51.

    Not in our library10.1177/2040622315609251

  15. 15.

    Chen G, et al. SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. J. Clin. Investig. 2009;119:2914-2924.

    Not in our library10.1172/jci35314

  16. 16.

    Lachowicz-Scroggins ME, et al. Abnormalities in MUC5AC and MUC5B protein in airway mucus in asthma. Am. J. Respiratory Crit. Care Med. 2016;194:1296-1299.

    Not in our library10.1164/rccm.201603-0526le

  17. 17.

    de Lamballerie, C. N. et al. Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia. Sci. Rep.9, 11493 (2019).

    Not in our library10.1038/s41598-019-48013-7

  18. 18.

    Steuerman, Y. et al. Dissection of influenza infection in vivo by single-cell RNA sequencing. Cell Syst.6, 679–691 (2018).

    Not in our library10.1016/j.cels.2018.05.008

  19. 19.

    Terrier, O. et al. Cellular transcriptional profiling in human lung epithelial cells infected by different subtypes of influenza A viruses reveals an overall down-regulation of the host p53 pathway. Virol. J.8, 285 (2011).

    Not in our library10.1186/1743-422x-8-285

  20. 20.
  21. 21.
  22. 22.

    Everman JL, et al. Functional genomics of CDHR3 confirms its role in HRV-C infection and childhood asthma exacerbations. J. Allergy Clin. Immunol. 2019;144:962-971.

    Not in our library10.1016/j.jaci.2019.01.052

  23. 23.

    Caliskan M, et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N. Engl. J. Med. 2013;368:1398-1407.

    Not in our library10.1056/nejmoa1211592

  24. 24.

    Poole A, et al. Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. J. Allergy Clin. Immunol. 2014;133:670-678 e612.

    Not in our library10.1016/j.jaci.2013.11.025

  25. 25.

    Voehringer D, Reese TA, Huang X, Shinkai K, Locksley RM. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J. Exp. Med. 2006;203:1435-1446.

    Not in our library10.1084/jem.20052448

  26. 26.

    Robinson D, et al. Revisiting Type 2-high and type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin. Exp. Allergy. 2017;47:161-175.

    Not in our library10.1111/cea.12880

  27. 27.

    Edwards KM, et al. Burden of human metapneumovirus infection in young children. N. Engl. J. Med. 2013;368:633-643.

    Not in our library10.1056/nejmoa1204630

  28. 28.

    Thompson WW, et al. Estimating influenza-associated deaths in the United States. Am. J. Public Health. 2009;99:S225-S230.

    Not in our library10.2105/ajph.2008.151944

  29. 29.

    Nair H, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545-1555.

    Not in our library10.1016/s0140-6736(10)60206-1

  30. 30.

    Weinberg GA, et al. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J. Pediatr. 2009;154:694-699.

    Not in our library10.1016/j.jpeds.2008.11.034

  31. 31.

    Tran, D. et al. Hospitalization for influenza A versus B. Pediatrics138, e20154643 (2016).

    Not in our library10.1542/peds.2015-4643

  32. 32.

    Schuster, J. E. et al. Severe enterovirus 68 respiratory illness in children requiring intensive care management. J. Clin. Virol. 70, 77–82 (2015).

    Not in our library10.1016/j.jcv.2015.07.298

  33. 33.

    Lambert KA, et al. The role of human rhinovirus (HRV) species on asthma exacerbation severity in children and adolescents. J. Asthma. 2018;55:596-602.

    Not in our library10.1080/02770903.2017.1362425

  34. 34.

    Mehta P, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033-1034.

    Not in our library10.1016/s0140-6736(20)30628-0

  35. 35.
  36. 36.

    Sungnak W, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 2020;26:681-687.

    Not in our library10.1038/s41591-020-0868-6

  37. 37.
  38. 38.

    Maughan, E. F. et al. Cell-intrinsic differences between human airway epithelial cells from children and adults. Preprint at https://www.biorxiv.org/content/10.1101/2020.04.20.027144v1 (2020).

    Not in our library10.1016/j.isci.2022.105409

  39. 39.

    Peters MC, et al. A transcriptomic method to determine airway immune dysfunction in T2-high and T2-low asthma. Am. J. Respir. Crit. Care Med. 2019;199:465-477.

    Not in our library10.1164/rccm.201807-1291oc

  40. 40.

    Advani S, Sengupta A, Forman M, Valsamakis A, Milstone AM. Detecting respiratory viruses in asymptomatic children. Pediatr. Infect. Dis. J. 2012;31:1221-1226.

    Not in our library10.1097/inf.0b013e318265a804

All 82 references

Cited by papers we hold 4

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.